Surrozen

IPO

Restoring Vision Through the Science of Renewal

Public · South San Francisco, United States · Founded 2016 · $133.0M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$133.0M
Last Round
$50.0M Series CJun 2020
Rounds
3
Type
Public

About

Surrozen is a clinical-stage biotechnology company pioneering Wnt-based therapeutics designed to repair and restore tissue function. The company's multifunctional biologics selectively activate Wnt signaling for ophthalmic diseases including diabetic macular edema, wet age-related macular degeneration, and uveitic macular edema. Founded in 2016, Surrozen focuses on helping patients preserve and regain vision through its regenerative medicine platform.

Summary

Surrozen is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $133.0M in total across 3 rounds, most recently a $50.0M Series C round in Jun 2020. Investors include The Column Group and Venrock.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Secondary MarketSecondary MarketMar 2025

Sign up to see all 4 rounds

Series A through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Surrozen on Indexed.vc
<a href="https://indexed.vc/companies/surrozen"><img src="https://indexed.vc/api/badge/company/surrozen" alt="Surrozen on Indexed.vc" width="260" height="76" /></a>